SLC36A1 Knockout HCT 116 Cell Line
Cat.No.:
EDC07739
Species:
Human
Cell Name:
HCT 116
Gene:
SLC36A1
Gene ID:
206358
Size:
1×10⁶cells
SLC36A1 Knockout HCT116 Cell Line is an exclusive upgraded CRISPR/Cas9 system-mediated gene knockout cell, with the advantages of Optimized Strategy Design, Efficient Cell Transfection, High-Performotion Cas9 Protein and Hassle-Free Cell Selection.
| Cat.No. | EDC07739 |
|---|---|
| Product Name | SLC36A1 Knockout HCT116 Cell Line |
| Species | Human |
| Cell Line | HCT 116 |
| Cellosaurus ID | CVCL_0291 |
| Cell Line Synonyms | HCT-116, HCT.116, HCT_116, HCT116, HCT116wt, HCT-116/P, HCT-116/parental, CoCL2 |
| NCBI Gene ID | |
| Gene | |
| Gene Synonyms | Dct1|LYAAT1|PAT1|TRAMD3 |
| Summary |
This gene encodes a member of the eukaryote-specific amino acid/auxin permease (AAAP) 1 transporter family. The encoded protein functions as a proton-dependent, small amino acid transporter. This gene is clustered with related family members on chromosome 5q33.1. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Apr 2015]
|
| Digestion Time | 3 min |
| Associated Diseases | Colorectal Carcinoma |
| Morphology | Adherent |
| Passage Ratio | 1:4~1:5 |
| Complete Culture Medium | mcCoy5A+10% FBS |
| Freezing Medium | 90% FBS/complete culture medium+10% DMSO |
* For research use only. Not intended for use in humans or animals, including clinical, therapeutic, or diagnostic purposes.
| Loci | STR Info (Sample Cell) Sample Cell Line: HCT 116 | STR Info (Cell bank) Cell Line: HCT 116 | ||||||
| Allele1 | Allele2 | Allele3 | Allele4 | Allele1 | Allele2 | Allele3 | Allele4 | |
| Amelogenin | X | X | ||||||
| CSF1PO | 7 | 10 | 7 | 9 | 10 | 11 | ||
| D2S1338 | 16 | 16 | ||||||
| D3S1358 | 12 | 17 | 18 | 19 | 12 | 18 | 19 | |
| D5S818 | 10 | 11 | 10 | 11 | ||||
| D7S820 | 11 | 12 | 11 | 12 | ||||
| D8S1179 | 10 | 12 | 14 | 15 | 10 | 12 | 14 | 15 |
| D13S317 | 10 | 12 | 10 | 12 | ||||
| D16S539 | 11 | 13 | 11 | 12 | 13 | 14 | ||
| D18S51 | 16 | 17 | 16 | 17 | ||||
| D19S433 | 12 | 13 | 12 | |||||
| D21S11 | 29 | 30 | 29 | 30 | ||||
| FGA | 18 | 23 | 18 | 23 | ||||
| Penta D | 9 | 13 | 9 | 13 | ||||
| Penta E | 12 | 13 | 14 | 12 | 13 | 14 | ||
| TH01 | 8 | 9 | 8 | 9 | ||||
| TPOX | 8 | 8 | ||||||
| vWA | 17 | 21 | 22 | 23 | 17 | 21 | 22 | 23 |
| D6S1043 | 13 | |||||||
| D12S391 | 17 | 21 | 22 | |||||
| D2S441 | 11 | 12 | ||||||
* STR authentication data of this cell line matches with that of cell lines sourced from ATCC, DSMZ, JCRB, and RIKEN databases.
Conclusion: The STR identification of this cell is correct.
Conclusion: The STR identification of this cell is correct.
FAQ
Which is better for studying SLC36A1 function, SLC36A1 Knockout HCT 116 Cell Line or SLC36A1 overexpression HCT 116 Cell Line?
The choice depends on whether you are studying SLC36A1 (PAT1)'s role as a proton-coupled amino acid transporter or its specific contributions to intestinal absorption of small amino acids and amino acid-like drugs. The Knockout line is the standard tool for asking whether PAT1 is required for proton-dependent uptake of glycine, proline, alanine, and γ-aminobutyric acid (GABA) — particularly relevant in HCT 116, which has intestinal epithelial origins. Overexpression is useful for testing transport activity in heterologous systems and for assessing drug-substrate interactions.
For PAT1 research, the EDITGENE Knockout in HCT 116 is highly informative for intestinal amino acid absorption and oral drug bioavailability studies — PAT1 contributes to apical uptake of certain GABA-related drugs (vigabatrin, gabapentin analogs) and δ-aminolevulinic acid (5-ALA used in photodynamic therapy). Rescue with wild-type or transport-deficient PAT1 enables structure-function studies, and is a critical specificity control for PAT1-mediated drug uptake research.
What are the application scenarios for this model?
Primary applications:
• Proton-coupled amino acid uptake: ³H-glycine, ³H-proline, or ³H-GABA uptake assays under varied extracellular pH conditions to characterize PAT1 transport activity.
• Drug uptake studies: 5-ALA (photodynamic therapy), vigabatrin, and gabapentin analog uptake assays — these drugs are substrates of PAT1 for intestinal absorption.
• Intestinal absorption modeling: PAT1-dependent oral bioavailability assessment for drug development in a colorectal epithelial context.
• Paralog studies: SLC36A2/SLC36A3/SLC36A4 expression analysis to characterize PAT family functional overlap.
EDITGENE recommends this model for researchers investigating proton-coupled amino acid transport, oral drug bioavailability, and amino acid-mimetic drug development.
Is this SLC36A1 Knockout HCT 116 Cell Line compatible with overexpression rescue experiments?
Yes. PAT1 rescue experiments require attention to proton-coupling and pH-dependence:
• Construct design: use a codon-modified SLC36A1 sequence with a small C-terminal tag (FLAG, HA). PAT1 has 11 transmembrane domains — N-terminal tags must not disrupt topology.
• Transport-deficient rescue: conserved residue mutations in proton-binding sites or substrate-binding pockets enable structure-function studies.
• pH-dependence: PAT1 transport is highly pH-sensitive — rescue assays should be performed under controlled extracellular pH conditions (typically pH 5.5-6.5 for optimal activity).
• Functional readout: rescue should restore proton-coupled amino acid uptake measured by ³H-glycine or related substrate uptake.
HCT 116 transduces efficiently with lentivirus and supports stable rescue line generation for intestinal-relevant transport studies.
* Research Use Disclaimer: Content is generated from publicly available research data, bioinformatic resources, and computational analyses for research reference only.
download